Mama-Match
Next Vial review
The plan selector is one of the cleanest I have seen: $199 a month, or $169, $149 and $99 over three, six and twelve months, and I checked every division — they are exact. Semaglutide and tirzepatide cost the same. And then you look at the top of that same page: "Doctor-Led Weight Loss Plans as Low as $249.97/Month". That figure is nowhere in the selector, and it is two and a half times what its cheapest plan costs.
- Ask about HSA/FSA
- Independently scored
- Confirm total cost
Our medical guides link to published research and official medication information. Provider reviews compare published costs and terms. These source checks do not replace clinical review or advice from your healthcare professional.
Other providers to compare with Next Vial
Providers to compare, with referral partners listed first. Placement and score are separate; some links earn MamaGLP a commission.
- Meet CoreAge Rx
Compounded semaglutide and tirzepatide with advertised flat prices; clarify the offer and renewal rules before paying.
- Meet yourEra
yourEra advertises semaglutide from $79 and tirzepatide from $159 with care and shipping included; confirm your refill amount and schedule.
- Meet Willow
Injections from $299 and $399/mo, with higher dose tiers; compounded tablets, named doctors and coverage in 36 states.
Next Vial at a glance
- Semaglutide
- $199/mo paying month to month
- Tirzepatide
- $199/mo paying month to month
- Coverage
- Not published
- Brand-name
- Compounded only
How we scored Next Vial
The Mama-Match Score of 53/100 for Next Vial combines six editorial assessments using the same weighted six-factor framework we apply to every provider. It is not a clinical quality rating. A recent source check does not mean every factor was rescored; read the published terms and the methodology alongside the number. Referral payments do not change the score.
Considers the full treatment cost, introductory offers and billing commitments.
Considers published state coverage and treatment-specific eligibility limits.
Considers cancellation deadlines, refund limits and prepaid commitments.
Considers the intake steps, payment timing and information available before enrollment.
Considers the described clinical team, appointment access and ways to contact a prescriber.
Considers follow-up appointments, refill reviews and access to ongoing clinical support.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- High
- Primary sources
Company website
Read on 18 August 2026. Next Vial LLC prices its plans clearly: $199 a month month-to-month, $169 on a three-month plan at $507, $149 on six months at $894 and $99 on twelve at $1,188, plus a microdose route at $159, $139 and $79 with no one-month option. I recalculated every division and they are all exact. Semaglutide and tirzepatide cost the same, so changing molecules costs nothing — the second seller on this page to price it that way. One thing on that same page spoils it: the headline advertises "Doctor-Led Weight Loss Plans as Low as $249.97/Month", a figure the selector never shows and two and a half times its cheapest plan. Free delivery, no membership and no insurance are stated on the homepage, and it carries a LegitScript seal. It publishes no states and no pharmacy. It came back clean in the FDA warning-letter index. ⚠ Its terms share 17,535 characters — 58% of the document, across fourteen blocks including a state-by-state directory of medical boards — with ClickSlim, also reviewed here. Every other pair among seven sites I checked shared nothing over 400 characters, so this is not the usual boilerplate; but the hosting, the portal, the catalogs and the clinicians all differ, so I am recording it as a shared document and not as common ownership.
Another option to compare
Visit Enhance MDWe may earn a commission if you sign up through this link.
Pricing
Prices re-verified
Compounded semaglutide
$199
Plan
One month, billed monthly
$199 a month month-to-month; $169 on the 3-month plan ($507), $149 on 6 months ($894) and $99 on 12 months ($1,188). Every division is exact. ⛔ The headline on that same page advertises "as low as $249.97/Month", a figure the selector never shows and 2.5 times the cheapest plan.
Compounded tirzepatide
$199
Plan
One month, billed monthly
The same $199 as semaglutide — the selector charges one price whichever molecule is chosen.
Compounded semaglutide
$99
Plan
12-month plan
$1,188 paid up front for twelve months, the deepest tier and marked best seller.
Compounded semaglutide
$159
Plan
Microdose, 3-month plan
$477 for three months. The microdose route has no one-month option at all; it starts at three.
Ask your account administrator whether the exact charges qualify for HSA/FSA reimbursement and what itemized receipts you need. Prices reflect what Next Vial disclosed publicly at our last review and change often; confirm the current number on Next Vial's site.
What we like
- A genuine month-to-month option at $199, not just prepaid plans
- Every total divides exactly: $507, $894, $1,188, $477, $834 and $948
- Semaglutide and tirzepatide cost the same, so switching molecules costs nothing
- There is a microdose route for both molecules
- Free delivery, no membership and no insurance, all on the homepage
- It carries a LegitScript certification seal
The caveats
- ⛔ The headline on that same page says "as low as $249.97/Month", above every plan it offers
- The $99 rate requires $1,188 up front
- The microdose route starts at three months; there is no single month
- It publishes no list of states
- It names no pharmacy
- Its terms share 17,535 characters with another seller on this page, and nothing explains it
Next Vial for moms: our verdict
The plan selector is one of the cleanest I have seen: $199 a month, or $169, $149 and $99 over three, six and twelve months, and I checked every division — they are exact. Semaglutide and tirzepatide cost the same. And then you look at the top of that same page: "Doctor-Led Weight Loss Plans as Low as $249.97/Month". That figure is nowhere in the selector, and it is two and a half times what its cheapest plan costs. It runs about $199/mo.
We looked at Next Vial the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What Next Vial actually costs
- Compounded semaglutide — One month, billed monthly: $199/mo
- Compounded tirzepatide — One month, billed monthly: $199/mo
- Compounded semaglutide — 12-month plan: $99/mo
- Compounded semaglutide — Microdose, 3-month plan: $159/mo
That's roughly in line with our list's median of ~$179/mo.
That price covers the consult, the medication and shipping.
The medications Next Vial prescribes
Next Vial lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.
Where it operates. Next Vial lists its coverage as: Not published.
Where Next Vial fits — and where it doesn't — for moms
A good fit if…
- you want to discuss both semaglutide and tirzepatide with your prescribing clinician.
Look elsewhere if…
- you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
- you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.
Trust, safety and oversight
Before choosing Next Vial, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.
The bottom line
Next Vial is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.
The bottom line
Best for: A mom who wants a real monthly price, with a large discount available if a year up front is possible.
Keep comparing Next Vial
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
Next Vial, answered
- How much does Next Vial cost?
- As of our last review, Next Vial's published pricing starts around $199/mo ($199/mo paying month to month semaglutide, $199/mo paying month to month tirzepatide). Confirm the current all-in price on Next Vial's site before you commit.
- Is Next Vial safe to use while breastfeeding?
- Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.
- Does Next Vial offer both semaglutide and tirzepatide?
- Yes — Next Vial offers both. The choice depends on the exact product, your medical history and your clinician’s assessment; PCOS or a history of gestational diabetes alone does not make one medication the preferred treatment.
- Where does Next Vial land in your ranking?
- Next Vial scores 53/100 on our Mama-Match Score (rank #189), which weights six things that matter to a first-timer. Compare the scorecards and our published methodology before choosing a program.
Prices, states and verification reflect what Next Vial disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is background information, not medical advice. Pregnancy and breastfeeding guidance depends on the drug and formulation. Read the current Wegovy label and Zepbound label. See our medical disclaimer and how we're funded.